BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31760648)

  • 41. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myelin Measurement Using Quantitative Magnetic Resonance Imaging: A Correlation Study Comparing Various Imaging Techniques in Patients with Multiple Sclerosis.
    Saccenti L; Hagiwara A; Andica C; Yokoyama K; Fujita S; Kato S; Maekawa T; Kamagata K; Le Berre A; Hori M; Wada A; Tateishi U; Hattori N; Aoki S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measuring injury and repair of myelin and neurons in multiple sclerosis.
    Arnold DL; Chen J
    Ernst Schering Res Found Workshop; 2005; (53):173-86. PubMed ID: 16315614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).
    KhorshidAhmad T; Acosta C; Cortes C; Lakowski TM; Gangadaran S; Namaka M
    Mol Neurobiol; 2016 Mar; 53(2):1092-1107. PubMed ID: 25579386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - A feasibility study.
    Sheth VR; Fan S; He Q; Ma Y; Annese J; Switzer R; Corey-Bloom J; Bydder GM; Du J
    Magn Reson Imaging; 2017 May; 38():87-94. PubMed ID: 28038965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord.
    Mottershead JP; Schmierer K; Clemence M; Thornton JS; Scaravilli F; Barker GJ; Tofts PS; Newcombe J; Cuzner ML; Ordidge RJ; McDonald WI; Miller DH
    J Neurol; 2003 Nov; 250(11):1293-301. PubMed ID: 14648144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination.
    Paz Soldan MM; Rodriguez M
    J Infect Dis; 2002 Dec; 186 Suppl 2():S248-53. PubMed ID: 12424705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promotion of endogenous remyelination in multiple sclerosis.
    Lucchinetti CF; Noseworthy JH; Rodriguez M
    Mult Scler; 1997 Apr; 3(2):71-5. PubMed ID: 9291156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. q-space Myelin Map imaging: A new imaging technique for treatment evaluation in multiple sclerosis.
    Kira JI
    J Neurol Sci; 2017 Feb; 373():358-359. PubMed ID: 28094009
    [No Abstract]   [Full Text] [Related]  

  • 50. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.
    Stankoff B; Freeman L; Aigrot MS; Chardain A; Dollé F; Williams A; Galanaud D; Armand L; Lehericy S; Lubetzki C; Zalc B; Bottlaender M
    Ann Neurol; 2011 Apr; 69(4):673-80. PubMed ID: 21337603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS.
    Pirko I; Ciric B; Gamez J; Bieber AJ; Warrington AE; Johnson AJ; Hanson DP; Pease LR; Macura SI; Rodriguez M
    FASEB J; 2004 Oct; 18(13):1577-9. PubMed ID: 15319372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diffusivity in multiple sclerosis lesions: At the cutting edge?
    Klistorner A; Wang C; Fofanova V; Barnett MH; Yiannikas C; Parratt J; You Y; Graham SL
    Neuroimage Clin; 2016; 12():219-26. PubMed ID: 27489769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
    Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct patterns of glia repair and remyelination in antibody-mediated demyelination models of multiple sclerosis and neuromyelitis optica.
    Liu Y; Given KS; Owens GP; Macklin WB; Bennett JL
    Glia; 2018 Dec; 66(12):2575-2588. PubMed ID: 30240044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.
    Fadda G; Brown RA; Longoni G; Castro DA; O'Mahony J; Verhey LH; Branson HM; Waters P; Bar-Or A; Marrie RA; Yeh EA; Narayanan S; Arnold DL; Banwell B;
    Lancet Child Adolesc Health; 2018 Mar; 2(3):191-204. PubMed ID: 30169254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pericytes in Multiple Sclerosis.
    Rivera FJ; Hinrichsen B; Silva ME
    Adv Exp Med Biol; 2019; 1147():167-187. PubMed ID: 31147878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
    Miller DH; Grossman RI; Reingold SC; McFarland HF
    Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.
    Vargas WS; Monohan E; Pandya S; Raj A; Vartanian T; Nguyen TD; Hurtado Rúa SM; Gauthier SA
    Neuroimage Clin; 2015; 9():369-75. PubMed ID: 26594620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.